Chief Business Officer play a crucial role in any startup. It takes an extraordinary person to fulfil the Chief Business Officer role. We have selected these Chief Business Officer’s for this list as they are inspiring for a variety of reasons – whether that’s pushing boundaries, creating groundbreaking products, or doing their bit to save the world.
Our analysts did their best to select be best, and most innovative Chief Business Officer’s. The list is in no particular order!
Liam Harrington
Chief Business Officer @ Greencastle Media Group
Follow Liam Harrington on Facebook, Twitter or Linkedin.
Read more about Greencastle Media Group on Crunchbase…
Joshua Roberts
Chief Business Officer @ Cannaray
Follow Joshua Roberts on Facebook, Twitter or Linkedin.
Spoiler title
Investor and entrepreneur with experience in institutional investment and trading, international real estate investment, and private market investment. Joshua worked for Highbridge Capital Management for over a decade in London and New York and established the European trading desk for the StatArb team in London. He started angel investing in 2010 and cannabis has been his investment focus since early 2017 in both the public and private markets.
Learn more about Joshua Roberts on Crunchbase…Cannaray is a leading European cannabis company stratifying medical THC and a CBD lifestyle brand. Read more about Cannaray on Crunchbase…
Mark Hodgson
Chief Business Officer @ Cervest
Follow Mark Hodgson on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”MarkHodgson101″]
Spoiler title
20+ years setting up and running commercial operations at Microsoft, Google and several UK tech startups. – 2011:2015: Global Head of Google Partner Program, Enterprise Division – 2015-2018: Chief Commercial Officer, Metail (AI and augmented reality) – Angel and Pre-Series Investor – Fellow of the RSA (Royal Society of Arts, Manufactures and Commerce) and has an – MSc in Rural and Regional Resources Planning from Aberdeen University.
Learn more about Mark Hodgson on Crunchbase…Cervest is cloud-based provider of AI-powered Climate Intelligence that helps organizations manage and adapt to asset-level risk globally. Read more about Cervest on Crunchbase…
David Raabe
Chief Business Officer (CBO) @ OWNR Technologies
Follow David Raabe on Facebook, Twitter or Linkedin.
Spoiler title
David has been involved in early stage companies for the majority of his career as a founder, investor and adviser. Most recently, David was part of the team that sold First Utility Ltd to Shell Petroleum Ltd. Prior to First Utility, David was a founder of LQD Wifi which was acquired by Verizon Communications in 2016. Prior experience includes being a founding member of LTAM, a specialist asset management firm based in New York which is part of Ladenburg Thalmann (NYSE: LTS). Including a few years of working in M&A and capital advisory for Citi Capital Markets and GP Bullhound, David has been involved in cross-border transactions involving clients in the US, UK, Germany, Spain, Turkey, The Middle East and Asia as well as raising growth capital for private companies across multiple geographies. David graduated with a degree in Political Science & History from The University of Vermont and received his MBA from NYU Stern School of Business.
Learn more about David Raabe on Crunchbase… Read more about OWNR Technologies on Crunchbase…
Laurence Barker
Chief Business Officer @ Dementia Discovery Fund
Follow Laurence Barker on Facebook, Twitter or Linkedin.
Dementia Discovery Fund is a specialist venture capital fund that invests in novel science to create meaningful new medicines. Read more about Dementia Discovery Fund on Crunchbase…
Simon Edmonds
Deputy Executive Chair & Chief Business Officer @ Innovate UK
Follow Simon Edmonds on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”simonedmondsTSB”]
Read more about Innovate UK on Crunchbase…
Sanat Rao
Chief Business Officer and Global Head of Finacle @ EdgeVerve
Follow Sanat Rao on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”sanat_rao”]
Spoiler title
Sanat Rao is the Director at EdgeVerve. Sanat has over 26 years of experience in international banking and technology led business transformations. His experience spans strategic partnerships with clients through their digital journey across multiple markets globally. In his present role, Sanat is responsible for growing the Finacle business and driving industry leadership with innovations in the banking space. Having started his career at ANZ Bank, a global financial institution headquartered in Australia, Sanat has had stints with marquee global financial technology organizations. In his previous role as Vice President and Senior Partner at IBM, he was responsible for a portfolio of offerings including cloud consulting services, CIO Advisory, core banking, digital foundation and payments in the BFSI space. He was also deeply engaged with FinTech companies in identifying and nurturing new partnerships that could prove disruptive in the market. Prior to that, for nearly 14 years till 2013, Sanat played a variety of global roles as part of the Infosys Finacle organization, helping build and scale the brand, with the last position as the Global Head of Client Services and Alliances. In this role, he was responsible driving global sales, client engagement, and strategic alliances for Finacle globally. Sanat’s expertise of the banking and financial technology industry is exemplary, having previously been responsible for Infosys’ global banking product strategy for the entire Finacle suite. Sanat is based in London but spends much of his time travelling globally to engage with clients.
Learn more about Sanat Rao on Crunchbase… Read more about EdgeVerve on Crunchbase…
Graham Griffiths
Chief Business Officer @ Vaccitech
Follow Graham Griffiths on Facebook, Twitter or Linkedin.
Spoiler title
Graham joins from Agalimmune Limited, a clinical stage Biotech developing directly administered immunotherapies for oncology indications. As co-founder and Chief Operating Officer, Graham led the licensing, funding and development of a novel cancer immunotherapy and played a lead role in the company’s successful sale to NASDAQ-listed BioLineRx in 2017. Graham qualified as a solicitor in 2005, before moving to co-found technology company MET that was subsequently sold to a group of private investors. He was an investment fund manager at Matrix Securities and for 9 years contributed across the portfolio of life sciences companies within the Animatrix Capital group. Graham’s focus was on developing early-stage products and companies targeting the diagnosis and treatment of cancer and infectious diseases. Graham holds a BA Hons degree in Law with French from Newcastle University.
Learn more about Graham Griffiths on Crunchbase…Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Read more about Vaccitech on Crunchbase…
Simon Lees
Chief Business Officer @ BrightTALK
Follow Simon Lees on Facebook, Twitter or Linkedin.
Spoiler title
Simon has over 20 years experience building content led, audience focussed b2b media businesses in two of the worlds leading professional and specialist information organisations, Reed Elsevier and Haymarket Media Group. With technology platforms increasingly driving user content creation and distribution, and having worked in commercial and leadership roles on media brands across multiple market verticals and geographies, Simon joined BrightTALK in 2014.
Learn more about Simon Lees on Crunchbase… Read more about BrightTALK on Crunchbase…
Simon Westbury
Chief Business Officer @ Digitain
Follow Simon Westbury on Facebook, Twitter or Linkedin.
Read more about Digitain on Crunchbase…
Helen Tayton-Martin
Chief Business Officer @ Adaptimmune
Follow Helen Tayton-Martin on Facebook, Twitter or Linkedin.
Spoiler title
Helen Tayton-Martin is COO of Adaptimmune Ltd. With a PhD in molecular immunology and an MBA from London Business School, she has nearly 20 years of experience working within the Pharma, biotech and consulting environment in disciplines across preclinical and clinical development, strategic planning, due diligence and business development.Helen joined Adaptimmune from Avidex/MediGene Ltd. where she was responsible for commercial development of the soluble TCR programme in cancer and HIV therapy. Helen is responsible for all development and commercial activities, including business development and implemented Adaptimmune’s strategic partnership with GSK.
Learn more about Helen Tayton-Martin on Crunchbase…Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. Read more about Adaptimmune on Crunchbase…
Welp Magazine
